3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
7
Fallopian Tube Neoplasms
6
Ovarian Neoplasms
5
Neoplasms
5
Colorectal Neoplasms
5
Prostatic Neoplasms
4
Glioblastoma
4
Solitary Fibrous Tumor, Pleural
3
Mesothelioma, Malignant
3
Carcinoma, Renal Cell
3
Triple Negative Breast Neoplasms
2
Sarcoma, Alveolar Soft Part
2
Sarcoma
2
Lung Neoplasms
2
Gliosarcoma
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Uveal Melanoma
1
Thyroid cancer, Hurthle cell
1
Thyroid Cancer, Papillary
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Neurofibromatosis 1
1
Neurofibroma, Plexiform
1
Neoplasm Metastasis
1
Melanoma
1
Leukemia, Myeloid, Acute
1
Kidney Neoplasms
1
Hypertension
1
Interventions
Temozolomide
7
Magnetic Resonance Spectroscopy
7
X-Rays
5
Phantoms, Imaging
5
Bevacizumab
5
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Carboplatin
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
Vemurafenib
2
Lapatinib
2
LY3023414
2
Everolimus
2
Etoposide
2
Erlotinib Hydrochloride
2
veliparib
1
pomalidomide
1
poly ICLC
1
picropodophyllin
1
marizomib
1
imetelstat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ependymoma
×
cediranib
×
Clear all
No trials found.